Aripiprazole and Mitotane: Interaction Details
- Aripiprazole
- Abilify MyciteAbilifyOpipza +4 more
- Mitotane
- Lysodren
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Aripiprazole and Mitotane interaction:
Aripiprazole
- Abilify Mycite
- Abilify
- Opipza
- Abilify Maintena
- Aristada
- Abilify Asimtufii
- Aristada Initio
What Happens When You Take Aripiprazole With Mitotane
What can happen when they are taken together (rated Major)
Reduced ARIPiprazole exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving ARIPiprazole together with strong can lower ARIPiprazole exposure. Extended release ARIPiprazole should not be coadministered with strong CYP3A inducers for longer than 14 days, while use for less than 14 days calls for no dosage adjustment.41
When these agents are used together, the usual ARIPiprazole dose should be doubled over 1 to 2 weeks, and it should be returned to the normal dose once the CYP3A is stopped.32 If is needed for more than 2 weeks, patients taking Aristada(R) 441 mg IM monthly should have the dosage raised to 662 mg monthly.5 Because the Aristada Initio(TM) dose cannot be changed, concomitant use with it should be avoided.6
The Aripiprazole and Mitotane Interaction, Explained
Mitotane can lower the amount of aripiprazole in your body. Mitotane speeds up a liver enzyme () that breaks down aripiprazole, so the medicine gets cleared faster. That could make aripiprazole work less well, and symptoms such as mood changes or psychosis could return or worsen.
Please don't change or stop either medicine on your own. Your care team can manage this, often by adjusting your aripiprazole dose over time and checking in with you more closely. Tell your pharmacist or doctor you take both, and report any change in how you feel.
Mechanism: Mitotane is a strong . It increases -mediated of aripiprazole (also a ), which lowers exposure ( and ). Aripiprazole is not a (dehydroaripiprazole is an active ), so reduced exposure means reduced effect and risk of relapse.
- Severity/evidence: major, probable. Onset unspecified. effects typically develop over weeks and persist after mitotane is stopped.
- Management: Per labeling for strong CYP3A , double the usual oral dose over 1 to 2 weeks, and return to the usual dose when the inducer is stopped. No adjustment is needed for under 14 days.
- Avoid extended-release aripiprazole with the inducer beyond 14 days. For Aristada, 441 mg monthly may go to 662 mg monthly if use exceeds 2 weeks. Avoid with Aristada Initio, as its dose cannot be modified.
- Monitor clinical response and tolerability.
See the 7 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Aripiprazole and Mitotane Interact
The likely mechanism
of -mediated of ARIPiprazole
How to Manage the Aripiprazole and Mitotane Interaction
Keep taking both medicines exactly as prescribed, and don't change doses yourself.
- Your care team may increase your aripiprazole dose (the label describes doubling the usual dose over 1 to 2 weeks) and tailor it to you.
- If mitotane is stopped, the dose is usually brought back to normal. Tell your team so this is timed correctly.
- Short overlap (under 14 days) may not need a dose change.
- Long-acting injectable forms may need a different plan, or may be avoided, so mention which form you use.
- Your team may monitor you more closely. Report any return of symptoms, or new side effects after a dose change.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Aripiprazole or Mitotane need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia
Giving carBAMazepine, a strong , twice daily together with once-daily ARIPiprazole lowered the of ARIPiprazole and its active , dehydro-ARIPiprazole, by 64% and 68%, respectively. In this study, 18 patients with schizophrenia (mean age 35.8 years) who had been receiving a fixed once-daily dose of ARIPiprazole (12 mg (n=3) or 24 mg (n=18)) for 3 to 5 weeks were started on carBAMazepine 200 mg twice daily for 1 week.
Blood samples were analyzed before carBAMazepine was started and 1 week after it was completed. The mean carBAMazepine plasma concentration reached was 9.3 mcg/mL.
A review of genotypes found no association between genotype and the changes in plasma concentrations of ARIPiprazole and dehydro-ARIPiprazole. The concentration ratio of ARIPiprazole to dehydro-ARIPiprazole remained unchanged throughout the study. Since carBAMazepine is a potent CYP3A inducer, CYP3A is the most likely mechanism of this interaction.7
-
Report 2 · Study title
Prescribing information: ABILIFY MAINTENA intramuscular extended-release injection, aripiprazole intramuscular extended-release injection
Aripiprazole and Mitotane: Common Questions
How serious is the Aripiprazole and Mitotane interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Aripiprazole and Mitotane interaction managed?
Keep taking both medicines exactly as prescribed, and don't change doses yourself. Your care team may increase your aripiprazole dose (the label describes doubling the usual dose over 1 to 2 weeks) and tailor it to you. If mitotane is stopped, the dose is usually brought back to normal. Tell your team so this is timed correctly. Short overlap (under 14 days) may not need a dose change. Long-acting… Management is individual — always follow your own care team's guidance.
Does taking Aripiprazole and Mitotane at different times of day help?
No. Taking them at different times of day does not prevent this one. Mitotane speeds up , an enzyme that breaks down aripiprazole, so aripiprazole can be cleared faster. That change lasts while mitotane is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Aripiprazole and Mitotane Interaction
Ask in your own words about taking Aripiprazole and Mitotane together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (7)
- Product Information: ABILIFY ASIMTUFII(R) intramuscular extended-release suspension, aripiprazole intramuscular extended-release suspension. Otsuka America Pharmaceutical Inc (per FDA), Rockville, MD, 2023.
- Product Information: ABILIFY MYCITE(R) oral tablets with sensor, aripiprazole oral tablets with sensor. Otsuka America Pharmaceutical Inc (per FDA), Rockville, MD, 2022. DailyMed
- Product Information: ABILIFY(R) oral tablets, oral solution, intramuscular injection, aripiprazole oral tablets, oral solution, intramuscular injection. Otsuka America Pharmaceutical Inc (per FDA), Rockville, MD, 2022. DailyMed
- Product Information: ABILIFY MAINTENA(R) intramuscular extended-release injection, aripiprazole intramuscular extended-release injection. Otsuka America Pharmaceutical Inc (per FDA), Rockville, MD, 2020.
- Product Information: ARISTADA(R) intramuscular extended-release injection, aripiprazole lauroxil intramuscular extended-release injection. Alkermes Inc (per FDA), Waltham, MA, 2018.
- Product Information: ARISTADA INITIO (R) intramuscular extended-release injection, aripiprazole lauroxil intramuscular extended-release injection. Alkermes, Inc (per manufacturer), Waltham, MA, 2020.
- Nakamura A, Mihara K, Nagai G, et al: Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia. Ther Drug Monit 2009; 31(5):575-578. PubMed
Other Serious Interactions of Aripiprazole and Mitotane
Also serious with Aripiprazole
- Ketoconazole TopicalContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
- DronedaroneContraindicated
Also serious with Mitotane
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Aripiprazole
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- American HelleboreMajor
- ArsenicMajor
- + 246 more
With Mitotane
- Activated CharcoalMajor
- Slippery ElmModerate
- GlucomannanModerate
- TragacanthModerate
- Coffee CharcoalModerate
- European MandrakeModerate
- Guar GumModerate
- Gum ArabicModerate
- + 9 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.